JPWO2021078835A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021078835A5
JPWO2021078835A5 JP2022523448A JP2022523448A JPWO2021078835A5 JP WO2021078835 A5 JPWO2021078835 A5 JP WO2021078835A5 JP 2022523448 A JP2022523448 A JP 2022523448A JP 2022523448 A JP2022523448 A JP 2022523448A JP WO2021078835 A5 JPWO2021078835 A5 JP WO2021078835A5
Authority
JP
Japan
Prior art keywords
amount
pharmaceutical composition
composition according
group
filler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022523448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022553313A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/079698 external-priority patent/WO2021078835A1/fr
Publication of JP2022553313A publication Critical patent/JP2022553313A/ja
Publication of JPWO2021078835A5 publication Critical patent/JPWO2021078835A5/ja
Pending legal-status Critical Current

Links

JP2022523448A 2019-10-23 2020-10-22 セレキシパグを含む医薬組成物 Pending JP2022553313A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2019/078905 2019-10-23
EP2019078905 2019-10-23
PCT/EP2020/079698 WO2021078835A1 (fr) 2019-10-23 2020-10-22 Composition pharmaceutique comprenant du sélexipag

Publications (2)

Publication Number Publication Date
JP2022553313A JP2022553313A (ja) 2022-12-22
JPWO2021078835A5 true JPWO2021078835A5 (fr) 2023-10-30

Family

ID=75620412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022523448A Pending JP2022553313A (ja) 2019-10-23 2020-10-22 セレキシパグを含む医薬組成物

Country Status (14)

Country Link
US (1) US20220401441A1 (fr)
EP (1) EP4048235A1 (fr)
JP (1) JP2022553313A (fr)
KR (1) KR20220087443A (fr)
CN (1) CN114555088A (fr)
AU (1) AU2020369912A1 (fr)
BR (1) BR112022007207A2 (fr)
CA (1) CA3154802A1 (fr)
EC (1) ECSP22040921A (fr)
IL (1) IL292354A (fr)
JO (1) JOP20220093A1 (fr)
MX (1) MX2022004882A (fr)
PE (1) PE20221455A1 (fr)
WO (1) WO2021078835A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023195957A1 (fr) * 2022-04-05 2023-10-12 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Comprimé pelliculé comprenant du selexi̇pag traité par granulation humide
WO2023195953A1 (fr) * 2022-04-05 2023-10-12 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Comprimé pelliculé comprenant du selexi̇pag
WO2023195954A1 (fr) * 2022-04-05 2023-10-12 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Comprimé pelliculé comprenant une dispersion solide de sélexi̇pag
WO2024144679A2 (fr) * 2022-12-28 2024-07-04 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulation en comprimé comprenant du selexi̇pag

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI316055B (fr) 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
DK2246336T3 (da) 2008-02-28 2020-07-20 Nippon Shinyaku Co Ltd Fibroseinhibitor
WO2009154246A1 (fr) 2008-06-19 2009-12-23 日本新薬株式会社 Agent thérapeutique pour un dysfonctionnement érectile
WO2009157397A1 (fr) 2008-06-23 2009-12-30 日本新薬株式会社 Agent thérapeutique pour une lésion au tractus intestinal accompagnant l’administration d’un anti-inflammatoire nonstéroïdien
WO2009157396A1 (fr) 2008-06-23 2009-12-30 日本新薬株式会社 Agent thérapeutique pour la sténose du canal spinal
CN102065864B (zh) 2008-06-23 2012-11-21 日本新药株式会社 炎性肠病治疗剂
KR102705198B1 (ko) 2009-06-26 2024-09-11 니뽄 신야쿠 가부시키가이샤 결정
WO2011024874A1 (fr) 2009-08-26 2011-03-03 日本新薬株式会社 Sels d'addition avec une base
EP2741738A1 (fr) 2011-08-12 2014-06-18 Ascendis Pharma A/S Composition à libération prolongée de prostacycline
US20150272874A1 (en) 2012-10-29 2015-10-01 Cardio Incorporated Pulmonary disease-specific therapeutic agent
AU2016366073B2 (en) * 2015-12-02 2021-08-26 Nippon Shinyaku Co., Ltd. Pharmaceutical composition containing 2-{4-[N-(5,6- diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N- (methylsulfonyl)acetamide
JOP20190204A1 (ar) 2017-03-08 2019-09-05 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على سيليكسيباغ
US20200397700A1 (en) * 2018-02-21 2020-12-24 Nippon Shinyaku Co., Ltd. Granular composition, production method for granular composition, and dissolution property improvement method for granular composition
JP2022532076A (ja) * 2019-05-06 2022-07-13 アクテリオン ファーマシューティカルズ リミテッド サルコイドーシス関連肺高血圧症の治療方法

Similar Documents

Publication Publication Date Title
JP6588915B2 (ja) Azd9291を含む医薬組成物
ES2935800T3 (es) Forma de dosificación oral de ketamina
JP4970452B2 (ja) メトホルミン徐放性錠剤およびその製造方法
ES2354030T3 (es) Preparación farmacéutica sólida que comprende benzacepinas, y procedimiento de producción de la misma.
EP2205279B1 (fr) Combinaison pharmaceutique d'aliskirène et de valsartane
KR102221846B1 (ko) 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법
KR20100129776A (ko) 왁스를 포함하는 서방형 제형
KR20080039876A (ko) 높은 약물 충진 제형 및 투여형
JP2020500176A (ja) 医薬製剤
US20200330433A1 (en) Extended release pharmaceutical composition of apremilast
KR20060120596A (ko) 로피니롤의 신규 제형
KR20130010044A (ko) 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 서방형 약학 조성물 및 이의 제조방법
WO2010082220A2 (fr) Composition pharmaceutique à libération prolongée à base de quétiapine et son procédé de préparation
CA3154802A1 (fr) Composition pharmaceutique comprenant du selexipag
GB2414668A (en) Sustained release delivery system for tetracycline compounds
KR20190015329A (ko) 다파글리플로진 공결정의 약학 조성물
KR20070069105A (ko) 서방성 제제
US11576917B2 (en) Pharmaceutical compositions comprising Ibrutinib
US20100172984A1 (en) tablet dosage form comprising cetirizine and pseudoephedrine
JP5211040B2 (ja) ピリジルメチルスルフィニルベンズイミダゾールのための経口速放医薬製剤
JP2022522005A (ja) Tbn、又はその塩もしくは水和物を含む薬物組成物及びその製造方法
US20140010883A1 (en) Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
US9561242B2 (en) Doxycycline composition
JPWO2021078835A5 (fr)
TWI436760B (zh) 阿利克侖之蓋崙(galenical)調配物